X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (178) 178
Publication (15) 15
Patent (11) 11
Book / eBook (8) 8
Magazine Article (5) 5
Book Review (3) 3
Book Chapter (2) 2
Conference Proceeding (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (64) 64
index medicus (55) 55
hematology (43) 43
male (34) 34
female (33) 33
oncology (29) 29
middle aged (25) 25
aged (22) 22
mantle cell lymphoma (21) 21
adult (20) 20
minimal residual disease (17) 17
prognosis (15) 15
cancer (14) 14
lymphoma, mantle-cell - therapy (14) 14
lymphomas (14) 14
translocation, genetic (14) 14
abridged index medicus (13) 13
chronic lymphocytic-leukemia (13) 13
lymphoma, mantle-cell - genetics (13) 13
rituximab (13) 13
aged, 80 and over (12) 12
analysis (12) 12
chemotherapy (12) 12
lymphoma, mantle-cell - pathology (12) 12
research (12) 12
antineoplastic combined chemotherapy protocols - therapeutic use (11) 11
genes (11) 11
medical and health sciences (11) 11
medicin och hälsovetenskap (11) 11
mutation (11) 11
non-hodgkins-lymphoma (11) 11
expression (10) 10
immunoglobulin heavy chains - genetics (10) 10
leukemia (10) 10
molecular sequence data (10) 10
progression-free survival (10) 10
treatment outcome (10) 10
b-cell lymphoma (9) 9
base sequence (9) 9
follicular lymphoma (9) 9
immunochemotherapy (9) 9
polymerase chain reaction (9) 9
survival (9) 9
transplantation (9) 9
genetic aspects (8) 8
germany (8) 8
hemic and lymphatic diseases (8) 8
lymphocytes b (8) 8
lymphoma (8) 8
pcr (8) 8
acute lymphoblastic-leukemia (7) 7
chromosomes, human, pair 14 (7) 7
clinical medicine (7) 7
disease-free survival (7) 7
follow-up (7) 7
gene expression (7) 7
gene-expression (7) 7
genes, immunoglobulin (7) 7
immunoglobulins (7) 7
klinisk medicin (7) 7
life sciences (7) 7
lymphoma, b-cell - genetics (7) 7
neoplasm, residual - diagnosis (7) 7
pathogenesis (7) 7
polymerase-chain-reaction (7) 7
prospective randomized-trial (7) 7
relapse (7) 7
somatic hypermutation (7) 7
therapy (7) 7
adolescent (6) 6
deoxyribonucleic acid--dna (6) 6
dna methylation (6) 6
electricity (6) 6
gene (6) 6
german literature (6) 6
history (6) 6
history and criticism (6) 6
immunoglobulin (6) 6
long-term remission (6) 6
lymphoma, mantle-cell - mortality (6) 6
medicine & public health (6) 6
neoplasm, residual (6) 6
proteins (6) 6
time factors (6) 6
time quantitative pcr (6) 6
animals (5) 5
article (5) 5
blasting (5) 5
burkitt lymphoma - genetics (5) 5
burkitt's lymphoma (5) 5
chromosomes, human, pair 14 - genetics (5) 5
clinical trials (5) 5
cyclophosphamide - administration & dosage (5) 5
diagnosis (5) 5
disease (5) 5
flow cytometry (5) 5
genetics & heredity (5) 5
genomics (5) 5
heating (5) 5
hematopoietic stem cell transplantation (5) 5
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 9, pp. 1111 - 1122
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10044, pp. 565 - 575
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2018, Volume 378, Issue 13, pp. 1211 - 1223
Among patients with MCL, many of whom were at high risk, ibrutinib plus venetoclax led to a complete response in 62% at week 16. Among patients with a... 
MEDICINE, GENERAL & INTERNAL | BRUTONS TYROSINE KINASE | WORKING GROUP | PHASE | PROGRESSION-FREE SURVIVAL | RESPONSE ASSESSMENT | CHRONIC LYMPHOCYTIC-LEUKEMIA | NON-HODGKIN-LYMPHOMA | OPEN-LABEL | INHIBITOR | MINIMAL RESIDUAL DISEASE | Lymph Nodes - pathology | Prognosis | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Lymphoma, Mantle-Cell - mortality | Neoplasm, Residual | Bridged Bicyclo Compounds, Heterocyclic - adverse effects | Aged, 80 and over | Female | Historically Controlled Study | Lymphoma, Mantle-Cell - genetics | Pyrazoles - adverse effects | Administration, Oral | Pyrimidines - administration & dosage | Lymphoma, Mantle-Cell - drug therapy | Survival Rate | Bridged Bicyclo Compounds, Heterocyclic - administration & dosage | Bone Marrow Examination | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Pyrazoles - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Agammaglobulinaemia Tyrosine Kinase | Intention to Treat Analysis | Pyrimidines - adverse effects | Sulfonamides - adverse effects | Proto-Oncogene Proteins c-bcl-2 - antagonists & inhibitors | Aged | Mutation | Sulfonamides - administration & dosage | Protein-Tyrosine Kinases - antagonists & inhibitors | Treatment outcome | Safety and security measures | Drug therapy | Mantle cell lymphoma | Flow cytometry | p53 Protein | Leukemia | Clinical trials | Cancer therapies | Computed tomography | Vomiting | Bone marrow | Medical research | Risk groups | Hematology | Minimal residual disease | Diarrhea | Fatigue | Nausea | Patients | Lymphoma | Bruton's tyrosine kinase | Polymerase chain reaction | Chemotherapy | Lysis | Response rates | Lymphomas | Positron emission tomography
Journal Article
Nature Genetics, ISSN 1061-4036, 12/2012, Volume 44, Issue 12, pp. 1316 - 1320
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2013, Volume 31, Issue 3, pp. 308 - 313
PURPOSEWe report on a multicenter phase II trial of (90)yttrium-ibritumomab-tiuxetan ((90)YIT) as first-line stand-alone therapy for patients with follicular... 
Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2006, Volume 354, Issue 23, pp. 2419 - 2430
Journal Article
Journal of Accounting and Public Policy, ISSN 0278-4254, 01/2014, Volume 33, Issue 1, pp. 1 - 31
Journal Article
Journal Article